# Pyros Pharmaceuticals, Inc. — Form D

Pyros Pharmaceuticals, Inc. of Parsippany, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2020-04-13. The offering totals $4.0M, of which $430K was reported sold. Industry: Other.

## Offering

- Filed: 2020-04-13
- Form: D
- Accession: 0001809245-20-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $430K
- Remaining: $3.6M
- Investors: 6
- Date of first sale: 2020-03-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-364840

## Issuer

- Name: Pyros Pharmaceuticals, Inc.
- CIK: 0001809245
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 2001 Route 46, Suite 310, Parsippany, NJ, 07054
- Phone: 201-743-9468

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Michael Smith | Director | Austin, TX |
| Michael Smith | Executive Officer | Austin, TX |
| Edwin Urrutia | Director | Parsippany, NJ |
| Edwin Urrutia | Executive Officer | Parsippany, NJ |
| Ron Tilles | Director | Parsippany, NJ |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2022-04-04](https://search.stillhousedata.com/formd/0001809245-22-000003) | D | $5.0M | $450K |
| [2020-08-25](https://search.stillhousedata.com/formd/0001231919-20-000056) | D/A | $6.0M | $5.9M |

## More

- [CIK 1809245 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1809245&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001809245-20-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.